Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle exocytosis (GO:0016079) | 6.00937380 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.37421230 |
3 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.21096444 |
4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.10480771 |
5 | glutamate secretion (GO:0014047) | 5.08614772 |
6 | vocalization behavior (GO:0071625) | 4.96728696 |
7 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.91384725 |
8 | neuronal action potential propagation (GO:0019227) | 4.84431438 |
9 | neuron cell-cell adhesion (GO:0007158) | 4.79414064 |
10 | * ATP hydrolysis coupled proton transport (GO:0015991) | 4.76263706 |
11 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.76263706 |
12 | * transferrin transport (GO:0033572) | 4.71727989 |
13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.68083738 |
14 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.61821795 |
15 | regulation of synaptic vesicle transport (GO:1902803) | 4.59438666 |
16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.46951819 |
17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.44694232 |
18 | synaptic vesicle maturation (GO:0016188) | 4.44432547 |
19 | protein localization to synapse (GO:0035418) | 4.39702932 |
20 | * trivalent inorganic cation transport (GO:0072512) | 4.37645560 |
21 | * ferric iron transport (GO:0015682) | 4.37645560 |
22 | neurotransmitter secretion (GO:0007269) | 4.28043137 |
23 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.15668994 |
24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.15634666 |
25 | sodium ion export (GO:0071436) | 4.12553749 |
26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.10430062 |
27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.09448033 |
28 | neuron-neuron synaptic transmission (GO:0007270) | 4.07694239 |
29 | presynaptic membrane assembly (GO:0097105) | 4.03499473 |
30 | locomotory exploration behavior (GO:0035641) | 3.95349302 |
31 | protein localization to endosome (GO:0036010) | 3.88784853 |
32 | synaptic transmission, glutamatergic (GO:0035249) | 3.88711962 |
33 | * phagosome maturation (GO:0090382) | 3.88167891 |
34 | glutamate receptor signaling pathway (GO:0007215) | 3.85475585 |
35 | response to histamine (GO:0034776) | 3.85067246 |
36 | long-term synaptic potentiation (GO:0060291) | 3.83581243 |
37 | presynaptic membrane organization (GO:0097090) | 3.74815351 |
38 | L-amino acid import (GO:0043092) | 3.66143760 |
39 | amino acid import (GO:0043090) | 3.62811203 |
40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.54638183 |
41 | neurotransmitter transport (GO:0006836) | 3.53495800 |
42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52843755 |
43 | proline transport (GO:0015824) | 3.52418525 |
44 | postsynaptic membrane organization (GO:0001941) | 3.50416917 |
45 | melanin biosynthetic process (GO:0042438) | 3.49618471 |
46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.46584180 |
47 | positive regulation of synapse maturation (GO:0090129) | 3.45734716 |
48 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.43386871 |
49 | positive regulation of membrane potential (GO:0045838) | 3.41689183 |
50 | neuromuscular process controlling posture (GO:0050884) | 3.41113368 |
51 | synaptic vesicle endocytosis (GO:0048488) | 3.38136815 |
52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.37300944 |
53 | regulation of neurotransmitter secretion (GO:0046928) | 3.35164988 |
54 | exploration behavior (GO:0035640) | 3.30548718 |
55 | regulation of synaptic plasticity (GO:0048167) | 3.30248617 |
56 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.28641442 |
57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.28024777 |
58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26033141 |
59 | regulation of neurotransmitter levels (GO:0001505) | 3.25682183 |
60 | gamma-aminobutyric acid transport (GO:0015812) | 3.25463846 |
61 | oligosaccharide catabolic process (GO:0009313) | 3.23708143 |
62 | startle response (GO:0001964) | 3.21245547 |
63 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.20947728 |
64 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.18843577 |
65 | regulation of synapse structural plasticity (GO:0051823) | 3.18223723 |
66 | positive regulation of neurotransmitter transport (GO:0051590) | 3.17105152 |
67 | establishment of synaptic vesicle localization (GO:0097480) | 3.16747461 |
68 | synaptic vesicle transport (GO:0048489) | 3.16747461 |
69 | detection of calcium ion (GO:0005513) | 3.14293983 |
70 | glycosphingolipid catabolic process (GO:0046479) | 3.12691535 |
71 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.12341571 |
72 | regulation of glutamate secretion (GO:0014048) | 3.12267682 |
73 | clathrin coat assembly (GO:0048268) | 3.12060778 |
74 | cerebellar granule cell differentiation (GO:0021707) | 3.11507373 |
75 | regulation of neurotransmitter transport (GO:0051588) | 3.10404452 |
76 | long-term memory (GO:0007616) | 3.06141100 |
77 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.05471394 |
78 | behavioral response to cocaine (GO:0048148) | 3.05464885 |
79 | regulation of vesicle fusion (GO:0031338) | 3.04989801 |
80 | negative regulation of amino acid transport (GO:0051956) | 3.03000659 |
81 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.01866562 |
82 | vesicle docking (GO:0048278) | 3.00556633 |
83 | positive regulation of synaptic transmission (GO:0050806) | 2.99878595 |
84 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98439231 |
85 | neuron recognition (GO:0008038) | 2.98438630 |
86 | synaptic transmission (GO:0007268) | 2.98431255 |
87 | establishment of vesicle localization (GO:0051650) | 2.95877694 |
88 | melanin metabolic process (GO:0006582) | 2.95753282 |
89 | regulation of early endosome to late endosome transport (GO:2000641) | 2.93624061 |
90 | vesicle docking involved in exocytosis (GO:0006904) | 2.93376429 |
91 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.93022078 |
92 | activation of protein kinase A activity (GO:0034199) | 2.92638027 |
93 | striatum development (GO:0021756) | 2.91903803 |
94 | cellular potassium ion homeostasis (GO:0030007) | 2.91894518 |
95 | membrane depolarization (GO:0051899) | 2.90016762 |
96 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.89661996 |
97 | positive regulation of protein autophosphorylation (GO:0031954) | 2.88981357 |
98 | NADH metabolic process (GO:0006734) | 2.88693926 |
99 | long term synaptic depression (GO:0060292) | 2.87948883 |
100 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.86717784 |
101 | acidic amino acid transport (GO:0015800) | 2.86052652 |
102 | regulation of synaptic transmission (GO:0050804) | 2.85912747 |
103 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.83760397 |
104 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.83424874 |
105 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.83022628 |
106 | vesicle transport along microtubule (GO:0047496) | 2.82271562 |
107 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.82166941 |
108 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.81661530 |
109 | glycolipid catabolic process (GO:0019377) | 2.81196827 |
110 | behavioral defense response (GO:0002209) | 2.80976292 |
111 | behavioral fear response (GO:0001662) | 2.80976292 |
112 | calcium ion-dependent exocytosis (GO:0017156) | 2.80039511 |
113 | righting reflex (GO:0060013) | 2.79234076 |
114 | regulation of exocytosis (GO:0017157) | 2.78811095 |
115 | * iron ion transport (GO:0006826) | 2.78169838 |
116 | regulation of Rac protein signal transduction (GO:0035020) | 2.77422479 |
117 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.76312116 |
118 | regulation of synapse maturation (GO:0090128) | 2.75744739 |
119 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.75700191 |
120 | neurotransmitter uptake (GO:0001504) | 2.74809597 |
121 | response to thyroid hormone (GO:0097066) | 2.74579954 |
122 | serotonin metabolic process (GO:0042428) | 2.74545438 |
123 | potassium ion homeostasis (GO:0055075) | 2.74169386 |
124 | membrane depolarization during action potential (GO:0086010) | 2.73918979 |
125 | fear response (GO:0042596) | 2.73225905 |
126 | negative regulation of neurotransmitter transport (GO:0051589) | 2.72914753 |
127 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.70480726 |
128 | cellular copper ion homeostasis (GO:0006878) | 2.61744124 |
129 | secondary metabolite biosynthetic process (GO:0044550) | 2.60644647 |
130 | membrane docking (GO:0022406) | 2.60398685 |
131 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.60384256 |
132 | iron ion import (GO:0097286) | 2.58891519 |
133 | Rap protein signal transduction (GO:0032486) | 2.56910053 |
134 | regulation of dendritic spine development (GO:0060998) | 2.55888043 |
135 | ganglioside metabolic process (GO:0001573) | 2.55697864 |
136 | L-glutamate transport (GO:0015813) | 2.55563945 |
137 | positive regulation of vesicle fusion (GO:0031340) | 2.54229600 |
138 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.53902473 |
139 | inositol phosphate catabolic process (GO:0071545) | 2.53468482 |
140 | positive regulation of macroautophagy (GO:0016239) | 2.52522964 |
141 | COPI coating of Golgi vesicle (GO:0048205) | 2.52494918 |
142 | Golgi transport vesicle coating (GO:0048200) | 2.52494918 |
143 | ceramide catabolic process (GO:0046514) | 2.52209722 |
144 | inositol phosphate dephosphorylation (GO:0046855) | 2.49737849 |
145 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.49737849 |
146 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.47896918 |
147 | nerve growth factor signaling pathway (GO:0038180) | 2.46109475 |
148 | vesicle coating (GO:0006901) | 2.45937938 |
149 | sphingosine metabolic process (GO:0006670) | 2.45881766 |
150 | response to methylmercury (GO:0051597) | 2.44503892 |
151 | layer formation in cerebral cortex (GO:0021819) | 2.43042219 |
152 | neuromuscular process controlling balance (GO:0050885) | 2.43001084 |
153 | regulation of beta-amyloid formation (GO:1902003) | 2.42150231 |
154 | intracellular pH reduction (GO:0051452) | 2.40660312 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.52370369 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.68392363 |
3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.03787002 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99744102 |
5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.97553581 |
6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.77064942 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76628934 |
8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.71777988 |
9 | * TFEB_21752829_ChIP-Seq_HELA_Human | 2.67906634 |
10 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.59103363 |
11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.58425268 |
12 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.53325820 |
13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45760456 |
14 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.43392622 |
15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.40538700 |
16 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.38384218 |
17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.27644065 |
18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.23976664 |
19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.19050931 |
20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.18697749 |
21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.18070974 |
22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17011307 |
23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.15881017 |
24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.15751352 |
25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15249254 |
26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.10263067 |
27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.10263067 |
28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02935033 |
29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.02916510 |
30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99021607 |
31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.97049635 |
32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.96235451 |
33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.90145824 |
34 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.87659169 |
35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.87576654 |
36 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.86112812 |
37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85857145 |
38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.83983397 |
39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80998378 |
40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.80407675 |
41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.78115260 |
42 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.77416526 |
43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72586439 |
44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.71461665 |
45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.69847951 |
46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.68248671 |
47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68072441 |
48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.66635927 |
49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.64957523 |
50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64730907 |
51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63615601 |
52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.63041654 |
53 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61617220 |
54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61394557 |
55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61218773 |
56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.58776301 |
57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.57654073 |
58 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56825889 |
59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54985443 |
60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54943789 |
61 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.54028250 |
62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.53696467 |
63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.53049441 |
64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.52397578 |
65 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.52003012 |
66 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.47927058 |
67 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47647909 |
68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47269251 |
69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46113571 |
70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44844292 |
71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41523160 |
72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41149633 |
73 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39709764 |
74 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.37260628 |
75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36649143 |
76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.36104901 |
77 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.35971976 |
78 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35053741 |
79 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.33974515 |
80 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33854280 |
81 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.32580264 |
82 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.30958743 |
83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30629064 |
84 | JUN_21703547_ChIP-Seq_K562_Human | 1.30169884 |
85 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.29390072 |
86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29126388 |
87 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.28589808 |
88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28071814 |
89 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27895599 |
90 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.27482325 |
91 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27309801 |
92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26031574 |
93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.24897946 |
94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24691538 |
95 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.24312730 |
96 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23712610 |
97 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.23123372 |
98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22782036 |
99 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.21689885 |
100 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20698475 |
101 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20134998 |
102 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.19520374 |
103 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19253553 |
104 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18777031 |
105 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18493243 |
106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18405170 |
107 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.18323760 |
108 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.18174362 |
109 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.17719363 |
110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16412521 |
111 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.16383807 |
112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16325431 |
113 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16100994 |
114 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15143084 |
115 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.14674912 |
116 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14458083 |
117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13577935 |
118 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.13339549 |
119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12949402 |
120 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12594195 |
121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11675243 |
122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11405636 |
123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11400671 |
124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10301986 |
125 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.09547319 |
126 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.08692954 |
127 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08533865 |
128 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08204077 |
129 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.07982882 |
130 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.06283067 |
131 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.06145827 |
132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05310713 |
133 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.04992930 |
134 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04948142 |
135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04440921 |
136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04247444 |
137 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03154400 |
138 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00231182 |
139 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99995112 |
140 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98579910 |
141 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98123988 |
142 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97443301 |
143 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97293339 |
144 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97022227 |
145 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95130421 |
146 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94967693 |
147 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94941606 |
148 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94931757 |
149 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93723274 |
150 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93723274 |
151 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93224764 |
152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92171177 |
153 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92171177 |
154 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92148343 |
155 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.91533611 |
156 | AR_19668381_ChIP-Seq_PC3_Human | 0.91283814 |
157 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90352052 |
158 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89871505 |
159 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89842674 |
160 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88141098 |
161 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.88125852 |
162 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88017051 |
163 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88002460 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 5.33022261 |
2 | MP0004859_abnormal_synaptic_plasticity | 5.31253696 |
3 | MP0010234_abnormal_vibrissa_follicle | 3.94395908 |
4 | MP0003635_abnormal_synaptic_transmissio | 3.85370187 |
5 | MP0009046_muscle_twitch | 3.62390315 |
6 | MP0002877_abnormal_melanocyte_morpholog | 3.46549301 |
7 | MP0002064_seizures | 3.45165469 |
8 | MP0009745_abnormal_behavioral_response | 3.44405019 |
9 | MP0004270_analgesia | 3.34039472 |
10 | MP0001968_abnormal_touch/_nociception | 3.29310007 |
11 | MP0002063_abnormal_learning/memory/cond | 3.13352202 |
12 | MP0002736_abnormal_nociception_after | 2.91183853 |
13 | MP0002572_abnormal_emotion/affect_behav | 2.83768373 |
14 | MP0003950_abnormal_plasma_membrane | 2.76656785 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.66086529 |
16 | MP0002272_abnormal_nervous_system | 2.65415633 |
17 | MP0001501_abnormal_sleep_pattern | 2.63220894 |
18 | MP0002735_abnormal_chemical_nociception | 2.62302522 |
19 | MP0003656_abnormal_erythrocyte_physiolo | 2.31484428 |
20 | MP0001440_abnormal_grooming_behavior | 2.31426915 |
21 | MP0002822_catalepsy | 2.28805507 |
22 | MP0004147_increased_porphyrin_level | 2.20864861 |
23 | MP0002733_abnormal_thermal_nociception | 2.12259502 |
24 | MP0002067_abnormal_sensory_capabilities | 2.11439763 |
25 | MP0001970_abnormal_pain_threshold | 2.11108370 |
26 | MP0001486_abnormal_startle_reflex | 2.09475287 |
27 | MP0000015_abnormal_ear_pigmentation | 2.01730654 |
28 | MP0009780_abnormal_chondrocyte_physiolo | 1.95443804 |
29 | MP0003879_abnormal_hair_cell | 1.93325818 |
30 | MP0006276_abnormal_autonomic_nervous | 1.89813021 |
31 | MP0000372_irregular_coat_pigmentation | 1.89714937 |
32 | MP0010386_abnormal_urinary_bladder | 1.88300573 |
33 | MP0003329_amyloid_beta_deposits | 1.87046859 |
34 | MP0003191_abnormal_cellular_cholesterol | 1.84850793 |
35 | MP0001529_abnormal_vocalization | 1.81313564 |
36 | MP0002876_abnormal_thyroid_physiology | 1.76664200 |
37 | MP0005646_abnormal_pituitary_gland | 1.76274716 |
38 | MP0001984_abnormal_olfaction | 1.71899425 |
39 | MP0005423_abnormal_somatic_nervous | 1.69887700 |
40 | MP0000371_diluted_coat_color | 1.65452271 |
41 | MP0005386_behavior/neurological_phenoty | 1.65279064 |
42 | MP0004924_abnormal_behavior | 1.65279064 |
43 | MP0001905_abnormal_dopamine_level | 1.63971220 |
44 | MP0003183_abnormal_peptide_metabolism | 1.63311504 |
45 | MP0005408_hypopigmentation | 1.62790952 |
46 | MP0002837_dystrophic_cardiac_calcinosis | 1.62004978 |
47 | MP0002909_abnormal_adrenal_gland | 1.60390712 |
48 | MP0003787_abnormal_imprinting | 1.55741773 |
49 | MP0008569_lethality_at_weaning | 1.53414930 |
50 | MP0000013_abnormal_adipose_tissue | 1.51244455 |
51 | MP0002184_abnormal_innervation | 1.50573524 |
52 | MP0002557_abnormal_social/conspecific_i | 1.49707207 |
53 | MP0004811_abnormal_neuron_physiology | 1.49391154 |
54 | MP0005174_abnormal_tail_pigmentation | 1.48955340 |
55 | MP0010352_gastrointestinal_tract_polyps | 1.46657342 |
56 | MP0003122_maternal_imprinting | 1.46486979 |
57 | MP0005645_abnormal_hypothalamus_physiol | 1.44643447 |
58 | MP0004142_abnormal_muscle_tone | 1.44149685 |
59 | MP0002066_abnormal_motor_capabilities/c | 1.35696704 |
60 | MP0003633_abnormal_nervous_system | 1.34091591 |
61 | MP0009840_abnormal_foam_cell | 1.29430548 |
62 | MP0000604_amyloidosis | 1.29163238 |
63 | MP0005167_abnormal_blood-brain_barrier | 1.27403917 |
64 | MP0003172_abnormal_lysosome_physiology | 1.23509216 |
65 | MP0004858_abnormal_nervous_system | 1.19068430 |
66 | MP0008260_abnormal_autophagy | 1.19057447 |
67 | MP0006054_spinal_hemorrhage | 1.18384193 |
68 | MP0006082_CNS_inflammation | 1.17697504 |
69 | MP0010678_abnormal_skin_adnexa | 1.16307888 |
70 | MP0000955_abnormal_spinal_cord | 1.16227659 |
71 | MP0002882_abnormal_neuron_morphology | 1.16192950 |
72 | MP0004043_abnormal_pH_regulation | 1.16129479 |
73 | MP0001502_abnormal_circadian_rhythm | 1.15693711 |
74 | MP0005058_abnormal_lysosome_morphology | 1.15675352 |
75 | MP0001177_atelectasis | 1.14294128 |
76 | MP0001188_hyperpigmentation | 1.14031072 |
77 | MP0003631_nervous_system_phenotype | 1.13388911 |
78 | MP0000778_abnormal_nervous_system | 1.13263358 |
79 | MP0005257_abnormal_intraocular_pressure | 1.13123925 |
80 | MP0000343_altered_response_to | 1.11787297 |
81 | MP0005248_abnormal_Harderian_gland | 1.08653743 |
82 | MP0002229_neurodegeneration | 1.07659233 |
83 | MP0005535_abnormal_body_temperature | 1.00503676 |
84 | MP0003806_abnormal_nucleotide_metabolis | 0.97795477 |
85 | MP0002095_abnormal_skin_pigmentation | 0.97384382 |
86 | MP0002090_abnormal_vision | 0.96637151 |
87 | MP0008872_abnormal_physiological_respon | 0.92567691 |
88 | MP0001986_abnormal_taste_sensitivity | 0.91749831 |
89 | MP0002069_abnormal_eating/drinking_beha | 0.91113574 |
90 | MP0002638_abnormal_pupillary_reflex | 0.88696751 |
91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87354028 |
92 | MP0008877_abnormal_DNA_methylation | 0.86504454 |
93 | MP0005171_absent_coat_pigmentation | 0.85740234 |
94 | MP0005310_abnormal_salivary_gland | 0.85393405 |
95 | MP0005551_abnormal_eye_electrophysiolog | 0.84765718 |
96 | MP0003634_abnormal_glial_cell | 0.84547431 |
97 | MP0005075_abnormal_melanosome_morpholog | 0.82968638 |
98 | MP0008874_decreased_physiological_sensi | 0.82038690 |
99 | MP0001963_abnormal_hearing_physiology | 0.81932293 |
100 | MP0003690_abnormal_glial_cell | 0.79458347 |
101 | MP0003632_abnormal_nervous_system | 0.77818193 |
102 | MP0002152_abnormal_brain_morphology | 0.76427682 |
103 | MP0004510_myositis | 0.75114191 |
104 | MP0003646_muscle_fatigue | 0.75091768 |
105 | MP0005165_increased_susceptibility_to | 0.73868088 |
106 | MP0000358_abnormal_cell_content/ | 0.73179763 |
107 | MP0006035_abnormal_mitochondrial_morpho | 0.72907330 |
108 | MP0000427_abnormal_hair_cycle | 0.72826513 |
109 | MP0004742_abnormal_vestibular_system | 0.72750309 |
110 | MP0004145_abnormal_muscle_electrophysio | 0.71326797 |
111 | MP0001664_abnormal_digestion | 0.71277184 |
112 | MP0004484_altered_response_of | 0.71147193 |
113 | MP0003075_altered_response_to | 0.69914937 |
114 | MP0003186_abnormal_redox_activity | 0.69910177 |
115 | MP0000751_myopathy | 0.69373438 |
116 | MP0001186_pigmentation_phenotype | 0.66502989 |
117 | MP0003448_altered_tumor_morphology | 0.64495269 |
118 | MP0004085_abnormal_heartbeat | 0.64390792 |
119 | MP0000920_abnormal_myelination | 0.64258782 |
120 | MP0008057_abnormal_DNA_replication | 0.64129432 |
121 | MP0004215_abnormal_myocardial_fiber | 0.62582773 |
122 | MP0002139_abnormal_hepatobiliary_system | 0.61628042 |
123 | MP0005166_decreased_susceptibility_to | 0.61418332 |
124 | MP0002075_abnormal_coat/hair_pigmentati | 0.60884627 |
125 | MP0000747_muscle_weakness | 0.60733903 |
126 | MP0010307_abnormal_tumor_latency | 0.60522895 |
127 | MP0004885_abnormal_endolymph | 0.60081696 |
128 | MP0002332_abnormal_exercise_endurance | 0.59546117 |
129 | MP0005384_cellular_phenotype | 0.58037461 |
130 | MP0004233_abnormal_muscle_weight | 0.57808588 |
131 | MP0001324_abnormal_eye_pigmentation | 0.57528189 |
132 | MP0001765_abnormal_ion_homeostasis | 0.57069140 |
133 | MP0002254_reproductive_system_inflammat | 0.56881308 |
134 | MP0005621_abnormal_cell_physiology | 0.56602561 |
135 | MP0005379_endocrine/exocrine_gland_phen | 0.56416413 |
136 | MP0003195_calcinosis | 0.56250073 |
137 | MP0006036_abnormal_mitochondrial_physio | 0.55940525 |
138 | MP0002752_abnormal_somatic_nervous | 0.54240829 |
139 | MP0000569_abnormal_digit_pigmentation | 0.53936549 |
140 | MP0003123_paternal_imprinting | 0.53585922 |
141 | MP0002693_abnormal_pancreas_physiology | 0.52285053 |
142 | MP0004036_abnormal_muscle_relaxation | 0.51848496 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.05456805 |
2 | Atonic seizures (HP:0010819) | 5.85355117 |
3 | Epileptic encephalopathy (HP:0200134) | 5.34491856 |
4 | Focal seizures (HP:0007359) | 5.26532783 |
5 | Febrile seizures (HP:0002373) | 4.89294656 |
6 | Myokymia (HP:0002411) | 4.88142225 |
7 | Visual hallucinations (HP:0002367) | 4.77051216 |
8 | Absence seizures (HP:0002121) | 4.73210972 |
9 | Dialeptic seizures (HP:0011146) | 4.48252191 |
10 | Hyperventilation (HP:0002883) | 4.03418288 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 4.02066432 |
12 | Apathy (HP:0000741) | 3.67864094 |
13 | Disinhibition (HP:0000734) | 3.54885418 |
14 | Progressive cerebellar ataxia (HP:0002073) | 3.51334176 |
15 | Diminished motivation (HP:0000745) | 3.51243805 |
16 | Pheochromocytoma (HP:0002666) | 3.45130874 |
17 | Neuroendocrine neoplasm (HP:0100634) | 3.33753638 |
18 | Polyphagia (HP:0002591) | 3.21804871 |
19 | Abnormal eating behavior (HP:0100738) | 3.21297161 |
20 | Loss of speech (HP:0002371) | 3.09971428 |
21 | Acute necrotizing encephalopathy (HP:0006965) | 3.04751070 |
22 | Abnormal hair whorl (HP:0010721) | 3.00572142 |
23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.00480871 |
24 | Intention tremor (HP:0002080) | 2.89471094 |
25 | Gait imbalance (HP:0002141) | 2.87050204 |
26 | Broad-based gait (HP:0002136) | 2.86285419 |
27 | Supranuclear gaze palsy (HP:0000605) | 2.84251173 |
28 | Gaze-evoked nystagmus (HP:0000640) | 2.80233672 |
29 | Hypokinesia (HP:0002375) | 2.79302093 |
30 | Tetraplegia (HP:0002445) | 2.77924286 |
31 | Medial flaring of the eyebrow (HP:0010747) | 2.75195505 |
32 | Progressive inability to walk (HP:0002505) | 2.73751500 |
33 | Progressive macrocephaly (HP:0004481) | 2.73631405 |
34 | Abnormality of the corticospinal tract (HP:0002492) | 2.72442157 |
35 | Truncal ataxia (HP:0002078) | 2.69765563 |
36 | Congenital primary aphakia (HP:0007707) | 2.68829255 |
37 | Epileptiform EEG discharges (HP:0011182) | 2.68460438 |
38 | Dysostosis multiplex (HP:0000943) | 2.67571180 |
39 | Vacuolated lymphocytes (HP:0001922) | 2.66490345 |
40 | Ocular albinism (HP:0001107) | 2.66021764 |
41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.65699103 |
42 | Urinary urgency (HP:0000012) | 2.65448815 |
43 | Abnormality of binocular vision (HP:0011514) | 2.64122241 |
44 | Diplopia (HP:0000651) | 2.64122241 |
45 | Amblyopia (HP:0000646) | 2.63375068 |
46 | Cerebral hypomyelination (HP:0006808) | 2.62690201 |
47 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.61861056 |
48 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.61861056 |
49 | Failure to thrive in infancy (HP:0001531) | 2.60643203 |
50 | Inappropriate behavior (HP:0000719) | 2.59047698 |
51 | Nephrogenic diabetes insipidus (HP:0009806) | 2.55412211 |
52 | Agnosia (HP:0010524) | 2.54957547 |
53 | Axonal loss (HP:0003447) | 2.53434903 |
54 | Depression (HP:0000716) | 2.51868471 |
55 | Papillary thyroid carcinoma (HP:0002895) | 2.50393538 |
56 | Resting tremor (HP:0002322) | 2.48266808 |
57 | Anxiety (HP:0000739) | 2.48119461 |
58 | Poor eye contact (HP:0000817) | 2.46718005 |
59 | Mitochondrial inheritance (HP:0001427) | 2.46001014 |
60 | Iris hypopigmentation (HP:0007730) | 2.45782766 |
61 | Inability to walk (HP:0002540) | 2.42190865 |
62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.41890244 |
63 | Lower limb muscle weakness (HP:0007340) | 2.41076065 |
64 | Tetraparesis (HP:0002273) | 2.40305086 |
65 | Dysdiadochokinesis (HP:0002075) | 2.39108670 |
66 | Oligomenorrhea (HP:0000876) | 2.36616853 |
67 | Abnormal social behavior (HP:0012433) | 2.34504931 |
68 | Impaired social interactions (HP:0000735) | 2.34504931 |
69 | Poor suck (HP:0002033) | 2.34007802 |
70 | Dysmetria (HP:0001310) | 2.30624172 |
71 | Excessive salivation (HP:0003781) | 2.30074428 |
72 | Drooling (HP:0002307) | 2.30074428 |
73 | Acute encephalopathy (HP:0006846) | 2.26369768 |
74 | Mutism (HP:0002300) | 2.26060245 |
75 | Personality changes (HP:0000751) | 2.25765767 |
76 | Bradykinesia (HP:0002067) | 2.25572888 |
77 | Hypsarrhythmia (HP:0002521) | 2.24481460 |
78 | Delusions (HP:0000746) | 2.24449637 |
79 | Action tremor (HP:0002345) | 2.24084196 |
80 | Increased cerebral lipofuscin (HP:0011813) | 2.23510749 |
81 | Cerebral inclusion bodies (HP:0100314) | 2.18638520 |
82 | Increased CSF lactate (HP:0002490) | 2.18582697 |
83 | Status epilepticus (HP:0002133) | 2.18142901 |
84 | Generalized myoclonic seizures (HP:0002123) | 2.16967901 |
85 | Ankle clonus (HP:0011448) | 2.16247013 |
86 | Impaired smooth pursuit (HP:0007772) | 2.15599490 |
87 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.13969142 |
88 | Neuronal loss in central nervous system (HP:0002529) | 2.13884862 |
89 | Spastic tetraparesis (HP:0001285) | 2.11427206 |
90 | Limb dystonia (HP:0002451) | 2.11320501 |
91 | Diminished movement (HP:0002374) | 2.11249832 |
92 | Hepatocellular necrosis (HP:0001404) | 2.10805723 |
93 | Increased serum pyruvate (HP:0003542) | 2.10497410 |
94 | Abnormality of glycolysis (HP:0004366) | 2.10497410 |
95 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07165234 |
96 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07165234 |
97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07165234 |
98 | Insidious onset (HP:0003587) | 2.07153039 |
99 | Termporal pattern (HP:0011008) | 2.07153039 |
100 | Global brain atrophy (HP:0002283) | 2.06724687 |
101 | Protruding tongue (HP:0010808) | 2.06383494 |
102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06076037 |
103 | Mucopolysacchariduria (HP:0008155) | 2.06076037 |
104 | Neurofibrillary tangles (HP:0002185) | 2.05511221 |
105 | Degeneration of anterior horn cells (HP:0002398) | 2.03012450 |
106 | Abnormality of the anterior horn cell (HP:0006802) | 2.03012450 |
107 | Akinesia (HP:0002304) | 2.02741186 |
108 | Postural tremor (HP:0002174) | 2.02541172 |
109 | Urinary incontinence (HP:0000020) | 2.00810806 |
110 | Psychosis (HP:0000709) | 2.00454961 |
111 | Cutaneous melanoma (HP:0012056) | 2.00374267 |
112 | Nuclear cataract (HP:0100018) | 2.00129088 |
113 | Dementia (HP:0000726) | 1.99840862 |
114 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99248846 |
115 | Fetal akinesia sequence (HP:0001989) | 1.98573547 |
116 | Specific learning disability (HP:0001328) | 1.98117279 |
117 | Postural instability (HP:0002172) | 1.97885533 |
118 | Abnormality of the periventricular white matter (HP:0002518) | 1.97697828 |
119 | Poor coordination (HP:0002370) | 1.97447156 |
120 | Scanning speech (HP:0002168) | 1.97080098 |
121 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96691538 |
122 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96691538 |
123 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96691538 |
124 | Papilledema (HP:0001085) | 1.96412291 |
125 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.95762056 |
126 | Esotropia (HP:0000565) | 1.94991424 |
127 | Hemiparesis (HP:0001269) | 1.94938070 |
128 | Spinal muscular atrophy (HP:0007269) | 1.94463971 |
129 | Thyroid carcinoma (HP:0002890) | 1.93763187 |
130 | Generalized hypopigmentation (HP:0007513) | 1.92881513 |
131 | Blue irides (HP:0000635) | 1.92333527 |
132 | Absent speech (HP:0001344) | 1.92178384 |
133 | Vaginal atresia (HP:0000148) | 1.91676888 |
134 | Dysmetric saccades (HP:0000641) | 1.91512684 |
135 | Rigidity (HP:0002063) | 1.91225762 |
136 | Genital tract atresia (HP:0001827) | 1.91080367 |
137 | Heterochromia iridis (HP:0001100) | 1.90732618 |
138 | Abnormality of the labia minora (HP:0012880) | 1.90698836 |
139 | Impaired vibratory sensation (HP:0002495) | 1.89681477 |
140 | Progressive neurologic deterioration (HP:0002344) | 1.89663089 |
141 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.89643760 |
142 | Cholecystitis (HP:0001082) | 1.89327433 |
143 | Abnormal gallbladder physiology (HP:0012438) | 1.89327433 |
144 | Spastic gait (HP:0002064) | 1.88126395 |
145 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.87371186 |
146 | Clonus (HP:0002169) | 1.86072697 |
147 | Gait ataxia (HP:0002066) | 1.85335964 |
148 | Autoamputation (HP:0001218) | 1.84660551 |
149 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.84656051 |
150 | Unsteady gait (HP:0002317) | 1.84309217 |
151 | Choreoathetosis (HP:0001266) | 1.84011990 |
152 | Rapidly progressive (HP:0003678) | 1.83628950 |
153 | Hyperthyroidism (HP:0000836) | 1.83370222 |
154 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.81833098 |
155 | Sensorimotor neuropathy (HP:0007141) | 1.80700616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 4.44278376 |
2 | NTRK3 | 4.03658258 |
3 | MAP3K12 | 3.68065746 |
4 | EPHA4 | 3.27089497 |
5 | MAP3K9 | 3.16233650 |
6 | MAP3K4 | 2.97091545 |
7 | MAP2K7 | 2.94920544 |
8 | EIF2AK1 | 2.94687884 |
9 | RIPK4 | 2.88405391 |
10 | EIF2AK3 | 2.68933992 |
11 | ARAF | 2.65405871 |
12 | TRIM28 | 2.52006524 |
13 | PLK2 | 2.40736797 |
14 | LATS2 | 2.32256650 |
15 | DAPK2 | 2.25799757 |
16 | CDK19 | 2.25762261 |
17 | MINK1 | 2.07747059 |
18 | DAPK1 | 2.07337651 |
19 | AKT3 | 1.98963088 |
20 | GRK5 | 1.97935167 |
21 | ERBB3 | 1.95485120 |
22 | MAP2K4 | 1.88931334 |
23 | KSR2 | 1.86236201 |
24 | CAMKK2 | 1.84574402 |
25 | IRAK3 | 1.81764848 |
26 | CCNB1 | 1.68223147 |
27 | LIMK1 | 1.67480859 |
28 | MST4 | 1.67010382 |
29 | TSSK6 | 1.59881759 |
30 | PRPF4B | 1.57950514 |
31 | OXSR1 | 1.46762868 |
32 | MARK1 | 1.45721055 |
33 | BMPR2 | 1.45535018 |
34 | PAK6 | 1.45292317 |
35 | BRAF | 1.40804881 |
36 | MST1R | 1.40654753 |
37 | PNCK | 1.38840050 |
38 | MAP3K13 | 1.37828080 |
39 | NTRK1 | 1.37552164 |
40 | NME1 | 1.36333972 |
41 | MAP3K14 | 1.31432351 |
42 | ACVR1B | 1.31185999 |
43 | PRKCG | 1.29216880 |
44 | PBK | 1.29082292 |
45 | PDK3 | 1.28728457 |
46 | PDK4 | 1.28728457 |
47 | TESK1 | 1.23722878 |
48 | KSR1 | 1.22638391 |
49 | CAMKK1 | 1.22337658 |
50 | CDK5 | 1.19067258 |
51 | FRK | 1.17267445 |
52 | ALK | 1.11305869 |
53 | NTRK2 | 1.10300160 |
54 | CAMK2A | 1.08805419 |
55 | FES | 1.06827651 |
56 | PDK2 | 1.05050759 |
57 | MAP3K2 | 1.02250178 |
58 | CAMK2B | 0.95846445 |
59 | PTK2B | 0.91340290 |
60 | RAF1 | 0.91321243 |
61 | GRK7 | 0.87835278 |
62 | CSNK1A1L | 0.85371803 |
63 | SGK494 | 0.82231927 |
64 | SGK223 | 0.82231927 |
65 | STK38L | 0.81968447 |
66 | PRKCE | 0.81460224 |
67 | CDK14 | 0.80587112 |
68 | CDK18 | 0.80113796 |
69 | PAK4 | 0.79168465 |
70 | PRKD3 | 0.78739266 |
71 | YES1 | 0.77864120 |
72 | SGK2 | 0.75679986 |
73 | CDK15 | 0.74434712 |
74 | ABL2 | 0.74039536 |
75 | MAPK13 | 0.72849699 |
76 | WNK3 | 0.71969695 |
77 | FGR | 0.71375661 |
78 | CSNK1G3 | 0.69457912 |
79 | SIK3 | 0.68230850 |
80 | CSNK1G1 | 0.67886258 |
81 | TNIK | 0.65054111 |
82 | ADRBK2 | 0.64371462 |
83 | CAMK2D | 0.62124277 |
84 | MOS | 0.61916448 |
85 | MAP3K5 | 0.61706297 |
86 | MAP3K1 | 0.61554564 |
87 | CDK11A | 0.61364689 |
88 | TGFBR2 | 0.60445945 |
89 | STK39 | 0.60337546 |
90 | STK38 | 0.60309688 |
91 | NEK1 | 0.59122366 |
92 | DAPK3 | 0.58985779 |
93 | CAMK2G | 0.55965983 |
94 | BRSK1 | 0.55830470 |
95 | PDPK1 | 0.55289836 |
96 | PDK1 | 0.54206667 |
97 | JAK1 | 0.52226720 |
98 | MAP2K1 | 0.52150010 |
99 | SCYL2 | 0.51497396 |
100 | FER | 0.51219167 |
101 | BCR | 0.47764208 |
102 | CDK6 | 0.47133711 |
103 | CAMK1 | 0.46694571 |
104 | ERBB4 | 0.46685586 |
105 | SGK1 | 0.46502537 |
106 | ADRBK1 | 0.45754242 |
107 | UHMK1 | 0.44949680 |
108 | PRKCH | 0.44800952 |
109 | MET | 0.43997068 |
110 | CSNK1G2 | 0.43673437 |
111 | EIF2AK2 | 0.43269561 |
112 | STK16 | 0.42743481 |
113 | PDGFRA | 0.41871038 |
114 | MAPK10 | 0.41006193 |
115 | PINK1 | 0.40228773 |
116 | RET | 0.40036870 |
117 | DYRK1A | 0.39868231 |
118 | SGK3 | 0.39777935 |
119 | PTK2 | 0.39581933 |
120 | RIPK1 | 0.35159462 |
121 | SIK2 | 0.34273610 |
122 | PAK3 | 0.33891368 |
123 | NME2 | 0.33621585 |
124 | STK11 | 0.32875896 |
125 | PLK3 | 0.32530420 |
126 | BMPR1B | 0.31150786 |
127 | MYLK | 0.31033160 |
128 | SYK | 0.30404567 |
129 | PRKACA | 0.29681591 |
130 | PRKCA | 0.29644648 |
131 | CDK8 | 0.29432296 |
132 | TNK2 | 0.28526913 |
133 | RPS6KA3 | 0.26651830 |
134 | CSNK1A1 | 0.24282571 |
135 | PRKCB | 0.23327021 |
136 | NEK6 | 0.23287382 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.53852046 |
2 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.98697875 |
3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.97583113 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.68366549 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57277736 |
6 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.52669519 |
7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.44248200 |
8 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.39181519 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.35014497 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.33319445 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.31691661 |
12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.27440032 |
13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.04638236 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.94218543 |
15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93124148 |
16 | Insulin secretion_Homo sapiens_hsa04911 | 1.84110026 |
17 | Taste transduction_Homo sapiens_hsa04742 | 1.77171770 |
18 | Salivary secretion_Homo sapiens_hsa04970 | 1.77059695 |
19 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.74730372 |
20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74154366 |
21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63845600 |
22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.62001981 |
23 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60620102 |
24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.58834162 |
25 | Long-term depression_Homo sapiens_hsa04730 | 1.54533015 |
26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.54379070 |
27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.52153091 |
28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.50136946 |
29 | Protein export_Homo sapiens_hsa03060 | 1.49094104 |
30 | Renin secretion_Homo sapiens_hsa04924 | 1.45326751 |
31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.44989120 |
32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.42621214 |
33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.39645966 |
34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37016957 |
35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34827172 |
36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.32063894 |
37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27592998 |
38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24246180 |
39 | * Phagosome_Homo sapiens_hsa04145 | 1.23410240 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22050257 |
41 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.21901640 |
42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21092614 |
43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16762169 |
44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12125958 |
45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10715242 |
46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.09560173 |
47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08429454 |
48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98043213 |
49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97096655 |
50 | Lysosome_Homo sapiens_hsa04142 | 0.97050648 |
51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94543181 |
52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94282543 |
53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92472221 |
54 | Gap junction_Homo sapiens_hsa04540 | 0.88968212 |
55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87700089 |
56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86460269 |
57 | Phototransduction_Homo sapiens_hsa04744 | 0.86090477 |
58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85065222 |
59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84180694 |
60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83989244 |
61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83658375 |
62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83602643 |
63 | Legionellosis_Homo sapiens_hsa05134 | 0.83235432 |
64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81748391 |
65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.81186203 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77992221 |
67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77550505 |
68 | Shigellosis_Homo sapiens_hsa05131 | 0.77333907 |
69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74634295 |
70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74523946 |
71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74221215 |
72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73671156 |
73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68388883 |
74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68196374 |
75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66276697 |
76 | Glioma_Homo sapiens_hsa05214 | 0.61811276 |
77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58409907 |
78 | Proteasome_Homo sapiens_hsa03050 | 0.58055325 |
79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57283700 |
80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56797107 |
81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52620245 |
82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52548167 |
83 | Melanogenesis_Homo sapiens_hsa04916 | 0.52370489 |
84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51995638 |
85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51644805 |
86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51432124 |
87 | Tuberculosis_Homo sapiens_hsa05152 | 0.51010746 |
88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50814733 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47972392 |
90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46762166 |
91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44550553 |
92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43514772 |
93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42412260 |
94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.42020584 |
95 | Endocytosis_Homo sapiens_hsa04144 | 0.40754482 |
96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40102641 |
97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39628752 |
98 | Pertussis_Homo sapiens_hsa05133 | 0.39153874 |
99 | Prion diseases_Homo sapiens_hsa05020 | 0.39053694 |
100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37999442 |
101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37485015 |
102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37034993 |
103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35687306 |
104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35146477 |
105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34315897 |
106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32551739 |
107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32521568 |
108 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.31959018 |
109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31276376 |
110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31122249 |
111 | Axon guidance_Homo sapiens_hsa04360 | 0.30707540 |
112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30597303 |
113 | Alcoholism_Homo sapiens_hsa05034 | 0.30495406 |
114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28867276 |
115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27165541 |
116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26827036 |
117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26757173 |
118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26299713 |
119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25619767 |
120 | Mineral absorption_Homo sapiens_hsa04978 | 0.23433330 |
121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.22342360 |
122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.19948657 |
123 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.19937834 |
124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19568507 |
125 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.17990211 |
126 | Salmonella infection_Homo sapiens_hsa05132 | 0.17413096 |
127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15822266 |
128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14960720 |